by Agilent Technologies
Polaris HPLC Columns
Performs Well Under Aqueous Conditions
In areas like drug discovery where target compounds are increasingly polar, it is critical to have a reversed-phase column that performs well under aqueous conditions. Retention is critical, but cannot come with troublesome secondary interactions. Likewise, phase collapse and shifting retention times need to be avoided. The answer is our Polaris line of polar modified columns.
| Vendor | Agilent Technologies | Pore size | 180 |
| Brand | Agilent Polaris | Surface Area | 200 |
| Modifification | Silica/C18 | Carbon Load, % | 12.1 |
| Mode | Reversed-Phase | Endcapped | Yes |
| Particle Size | Operating Temperature | 60 | |
| Length | pH stability to | 10.0 | |
| Internal Diameter |
| Vendor | Brand | Mode | Modification | Int. diam. | Length | Particles | Pores | Price |
|---|---|---|---|---|---|---|---|---|
| Sepax Technologies | Sepax Bio 200 C18 | Reversed-Phase | Silica/C18 | 0.75 mm | 100 mm | 5.0 μm | 200 Å | On request |
| CERI | L-column ODS-P (PEEK-sleeved) | Reversed-Phase | Silica/C18 | 0.2 mm | 50 mm | 5.0 μm | 300 Å | On request |
| Tokyo Chemical Industry | Kaseisorb LC ODS 2000 | Reversed-Phase | Silica/C18 | 2.0 mm | 150 mm | 5.0 μm | 120 Å | 336.00 |
| Sepax Technologies | Sepax BR 120 C18 | Reversed-Phase | Silica/C18 | 2.1 mm | 150 mm | 1.8 μm | 120 Å | On request |
| Bonna-Agela Technologies | Durashell C18 | Reversed-Phase | Silica/C18 | 10.0 mm | 150 mm | 5.0 μm | 100 Å | On request |
| GL Sciences | Inertsil ODS-3 | Reversed-Phase | Silica/C18 | 4.0 mm | 75 mm | 4.0 μm | 100 Å | On request |
| Fortis Technologies | Fortis H2o | Reversed-Phase | Silica/C18 | 0.2 mm | 150 mm | 1.7 μm | — | On request |
| GL Sciences | Inertsil ODS-4 | Reversed-Phase | Silica/C18 | 4.6 mm | 250 mm | 3.0 μm | 100 Å | On request |
No customer reviews yet. Be the first to share your experience!
Reach thousands of researchers worldwide. Fill in your details and our team will contact you shortly.
